Coverage of recommended vaccinations in subjects with diabetes mellitus and ischemic heart disease: results for women and men.
Vaccination is an important public health strategy to prevent adverse health outcomes in the general population and in subjects with chronic diseases. It was the aim of this study to compare data on coverage of recommended vaccinations in men and women with diabetes mellitus and after myocardial infarction (MI) and to analyse trends in three different interview surveys: 1991, 1999 and 2006-07. The data show a rise in influenza vaccination coverage rate in men and women in the general population and in high-risk groups. However, coverage rates in all analysed groups were still strikingly low. Although in soft reported earlier surveys women were vaccinated more often than men, there was a reverse trend observed in the most recent survey. In the survey of 2006-07, men with diabetes or after MI had a higher chance of being vaccinated against influenza when compared to men without these diseases (age adjusted OR: 1.61; 95% CI: 1.29-1.99 and 1.61; 95% CI: 1.21-2.15, respectively). This was, however, not the case in women (OR: 1.10; 95% CI: 0.89-1.35 and 0.87; 95% CI: 0.58-1.33, respectively). Neither men nor women with diabetes mellitus or MI had a significantly higher chance of having pneumococcal vaccination when compared to subjects without these diseases. The observed sex-specific differences demand more research regarding the underlying causes. Strategies to reach higher vaccination coverage in men and women are needed.
Institute of Social Medicine, Centre for Public Health, Medical University of Vienna, Vienna, Austria. thomas.dorner@meduniwien.ac.at
Thomas Ernst
TE
Dorner
Eva
E
Ràsky
Katharina Viktoria
KV
Stein
Willibald Julius
WJ
Stronegger
Alexandra
A
Kautzky-Willer
Anita
A
Rieder
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001317:Austria; D003431:Cross-Cultural Comparison; D003920:Diabetes Mellitus / Q000453:epidemiology*; D004363:Drug Utilization; D005260:Female; D006306:Health Surveys; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D007252:Influenza Vaccines / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000453:epidemiology*; D017202:Myocardial Ischemia / Q000453:epidemiology*; D010342:Patient Acceptance of Health Care / Q000706:statistics & numerical data; D022242:Pneumococcal Vaccines / Q000008:administration & dosage*; D012307:Risk Factors; D012737:Sex Factors; D055815:Young Adult
D007252:Influenza Vaccines; D022242:Pneumococcal Vaccines
J Gen Intern Med. 2005 Jul;20(7):650-2
16050863
Euro Surveill. 2009 Dec 10;14(49):
20003909
Wien Med Wochenschr. 2004 Sep;154(17-18):426-32
15552231
Circulation. 2008 Dec 9;118(24):2596-648
19001027
Chest. 1995 Feb;107(2):457-62
7842778
Arch Intern Med. 2001 Dec 10-24;161(22):2702-8
11732935
Vaccine. 2010 Aug 31;28(38):6169-75
20659518
Eur Heart J. 2008 Dec;29(23):2909-45
19004841
Crit Care Med. 2010 Apr;38(4 Suppl):e52-7
19935415
Diabetes Res Clin Pract. 2008 Mar;79(3):510-7
18035444
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Jan;51(1):28-35
18185966
Diabetes Care. 2010 Jan;33 Suppl 1:S11-61
20042772
Wien Med Wochenschr. 2004 Sep;154(17-18):423-5
15552230
BMC Public Health. 2009 Jun 30;9:213
19563685
J Infect. 2009 Jun;58(6):446-58
19446340
Gesundheitswesen. 2010 Feb;72(2):e72-5
19795344
J Womens Health (Larchmt). 2004 Apr;13(3):341-9
15130263
Wien Med Wochenschr. 2004 Sep;154(17-18):391-3
15552224
JAMA. 2004 Dec 8;292(22):2715-2716
15585722
Hum Vaccin. 2010 Jul;6(7):566-71
20519968
Wien Med Wochenschr. 2007;157(5-6):98-101
17427004
Diabetes Care. 2005 Mar;28(3):514-20
15735180
Eur J Public Health. 2003 Sep;13(3 Suppl):67-72
14533752
Womens Health Issues. 2008 May-Jun;18(3):191-8
18457754
Wien Med Wochenschr. 2008;158(19-20):583-8
18998078
JAMA. 2003 Jan 8;289(2):179-86
12517228